Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma

Abstract

Let-7b-3p inhibits the development of LUAD and is an ideal novel therapeutic target for the treatment of LUAD.